arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

SUNDAY 10 OCTOBER 2021

Sunday 10 Oct

Plenary session 3 Viral infection associated Pulmonary Aspergillosis / Going Viral Going Fungal

Chair: Tihana Bicanic, UK, FECMM

09:00

PS3.1 Influenza

Paul Verweij, the Netherlands, FECMM

09:30

PS3.2 COVID-19

Martin Hoenigl, Austria, FECMM

10:00

Coffee break

10:15

Quiz the expert sessions

10:15

Q07 MIC testing in the lab

Maiken Arendrup, Denmark

10:15

Q08 Mucormycosis how to manage

Livio Pagano, Italy, FECMM & Sharon Chen, Australia, FECMM

10:15

Q09 TDM

Andreas Groll, FECMM

10:15

Q10 Radiology

Joanne Cleverley, UK

10:15

Q11 How to use new antifungals in kids

Fabianne Carlesse, Brazil

10:15

Q12 Mycological Diagnosis on the bedside: Where are we in 2021

John Perfect, USA & Toine Mercier, Belgium, FECMM

11:00

Poster session 2

12:00

Lunch

12:30

Sponsored Integrated Symposium 4

More information on www.timm2021.org/sponsored-symposia

14:15

Parallel Symposia 14-17

Symposium 14 Fungal respiratory infections in Cystic Fibrosis

Chairs: Jean-Philippe Bouchara, France & Michaela Lackner, Austria, FECMM

14:15

S14.1 Fungal infections in patients with cystic fibrosis

Michaela Lackner, Austria, FECMM

14:35

S14.2 Exophiala dermatitidis in cystic fibrosis

Jörg Steinmann, Germany, FECMM

14:55

S14.3 Immunotherapy

Darius Armstrong-James, UK

Symposium 15 Cryptococosis: From bench to bedside

14:15

S15.1 Advancing prevention and treatment of HIV-associated cryptococcal meningitis

14:35

S15.2 AMBITION trial and beyond

Joe Jarvis, UK

14:55

S15.3 Titan cells in cryptococcosis

Liz Ballou, UK

15:15

S15.4 Modifications of the cell wall in cryptococcosis

Liliane Mukaremera, UK

Symposium 16 Azoles, Echinocandins and Polyenes strenghts and weaknesses

Chair: Frederic Lamoth, Switzerland, FECMM & Marika Jürna-Ellam, Spain

14:15

S16.1 Azoles

14:35

S16.2 Echinocandins

Andrej Spec, USA, FECMM

14:55

S16.3 Polyenes and biofilms

Gordon Ramage, UK

15:15

S16.4 Breakthrough infections - Definitions, Epidemiology and Outcomes

Jeff Jenks, USA

Symposium 17 Management of immunoallergic fungal diseases

14:15

S17.1 Antifungal treatment in kids with allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization : where do we stand?

Adilia Warris, UK, FECMM

14:35

S17.2

Peter Cook, UK

14:55

S17.3 Impact of environmental approaches for allergen avoidance and asthma control

Jean-Pierre Gangneux, France, FECMM

15:15

S18.4 Mycology laboratory diagnostic capabilities in different areas of the world

15:45

Coffee break

16:15

Parallel Symposia 18-21

Symposium 18 Diagnosis of invasive aspergillosis: What is new?

Chair: Lewis White, UK, FECMM

16:15

S18.1 Maldi

16:35

S18.2 POC

Juergen Prattes, Austria, FECMM

16:55

S18.3 PCR Diagnosis

Lewis White, UK, FECMM

Symposium 19 Pre clinical anti fungal studies

Chairs: Alexandra Brand, UK & Mihai Mares, Romania, FECMM

16:15

S19.1 Tracking antifungals in the cell

Judy Berman, Israel

16:35

S19.2 Paradoxical growth

Carol Munro, UK

16:55

S19.3 Screens for new compounds

17:15

S19.4 Animal models

David Andes, USA

Symposium 20 Improving outcomes for patients with invasive fungal infection in routine care in LMIC

Chair: Rita Oladele, Nigeria, FECMM

16:15

S20.1 From trials to routine care - strengthening pathways to effective implementation – lessons from cryptococcal meningitis and the UNITAID/CHAI programme for advanced HIV disease

Angela Loyse, UK

16:35

S20.2 CDC Mycology Branch programme to support diagnosis and treatment in LMIC

16:55

S20.3 Improving outcomes for patients with histoplasmosis, mycetoma and chromoblastomycosis in South America

Flavio Queiros Telles, Brazil

Symposium 21 Invasive fungal infections in special populations

Chair: Volkan Özenci, Sweden

16:15

S21.1 Neonatal candiasis

Tom Walsh, UK, FECMM

16:35

S21.2 ECMO and dialysis

Robert Krause, Austria, FECMM

16:55

S21.3 Obese patients

Roger Brüggemann, the Netherlands, FECMM

18:00

Sponsored Diagnostic Symposium 2

More information on https://www.timm2021.org/sponsored-symposia/

19:30

Congress dinner

Sunday 10 Oct

Plenary session 3 Viral infection associated Pulmonary Aspergillosis / Going Viral Going Fungal

Chair: Tihana Bicanic, UK, FECMM

09:00

PS3.1 Influenza

Paul Verweij, the Netherlands, FECMM

09:30

PS3.2 COVID-19

Martin Hoenigl, Austria, FECMM

10:00

Coffee break

10:15

Quiz the expert sessions

10:15

Q07 MIC testing in the lab

Maiken Arendrup, Denmark

10:15

Q08 Mucormycosis how to manage

Livio Pagano, Italy, FECMM & Sharon Chen, Australia, FECMM

10:15

Q09 TDM

Andreas Groll, FECMM

10:15

Q10 Radiology

Joanne Cleverley, UK

10:15

Q11 How to use new antifungals in kids

Fabianne Carlesse, Brazil

10:15

Q12 Mycological Diagnosis on the bedside: Where are we in 2021

John Perfect, USA & Toine Mercier, Belgium, FECMM

11:00

Poster session 2

12:00

Lunch

12:30

Sponsored Integrated Symposium 4

More information on www.timm2021.org/sponsored-symposia

14:15

Parallel Symposia 14-17

Symposium 14 Fungal respiratory infections in Cystic Fibrosis

Chairs: Jean-Philippe Bouchara, France & Michaela Lackner, Austria, FECMM

14:15

S14.1 Fungal infections in patients with cystic fibrosis

Michaela Lackner, Austria, FECMM

14:35

S14.2 Exophiala dermatitidis in cystic fibrosis

Jörg Steinmann, Germany, FECMM

14:55

S14.3 Immunotherapy

Darius Armstrong-James, UK

Symposium 15 Cryptococosis: From bench to bedside

14:15

S15.1 Advancing prevention and treatment of HIV-associated cryptococcal meningitis

14:35

S15.2 AMBITION trial and beyond

Joe Jarvis, UK

14:55

S15.3 Titan cells in cryptococcosis

Liz Ballou, UK

15:15

S15.4 Modifications of the cell wall in cryptococcosis

Liliane Mukaremera, UK

Symposium 16 Azoles, Echinocandins and Polyenes strenghts and weaknesses

Chair: Frederic Lamoth, Switzerland, FECMM

14:15

S16.1 Azoles

14:35

S16.2 Echinocandins

Andrej Spec, USA, FECMM

14:55

S16.3 Polyenes and biofilms

Gordon Ramage, UK

15:15

S16.4 Breakthrough infections - Definitions, Epidemiology and Outcomes

Jeff Jenks, USA

Symposium 17 Management of immunoallergic fungal diseases

14:15

S17.1 Antifungal treatment in kids with allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization : where do we stand?

Adilia Warris, UK, FECMM

14:35

S17.2

Peter Cook, UK

14:55

S17.3 Impact of environmental approaches for allergen avoidance and asthma control

Jean-Pierre Gangneux, France, FECMM

15:15

S18.4 Mycology laboratory diagnostic capabilities in different areas of the world

15:45

Coffee break

16:15

Parallel Symposia 18-21

Symposium 18 Diagnosis of invasive aspergillosis: What is new?

Chair: Lewis White, UK, FECMM

16:15

S18.1 Maldi

16:35

S18.2 POC

Juergen Prattes, Austria, FECMM

16:55

S18.3 PCR Diagnosis

Lewis White, UK, FECMM

Symposium 19 Pre clinical anti fungal studies

Chairs: Alexandra Brand, UK & Mihai Mares, Romania, FECMM

16:15

S19.1 Tracking antifungals in the cell

Judy Berman, Israel

16:35

S19.2 Paradoxical growth

Carol Munro, UK

16:55

S19.3 Screens for new compounds

17:15

S19.4 Animal models

David Andes, USA

Symposium 20 Improving outcomes for patients with invasive fungal infection in routine care in LMIC

Chair: Rita Oladele, Nigeria, FECMM

16:15

S20.1 From trials to routine care - strengthening pathways to effective implementation – lessons from cryptococcal meningitis and the UNITAID/CHAI programme for advanced HIV disease

Angela Loyse, UK

16:35

S20.2 CDC Mycology Branch programme to support diagnosis and treatment in LMIC

16:55

S20.3 Improving outcomes for patients with histoplasmosis, mycetoma and chromoblastomycosis in South America

Flavio Queiros Telles, Brazil

Symposium 21 Invasive fungal infections in special populations

Chair: Volkan Özenci, Sweden

16:15

S21.1 Neonatal candiasis

Tom Walsh, UK, FECMM

16:35

S21.2 ECMO and dialysis

Robert Krause, Austria, FECMM

16:55

S21.3 Obese patients

Roger Brüggemann, the Netherlands, FECMM

18:00

Sponsored Diagnostic Symposium 2

More information on https://www.timm2021.org/sponsored-symposia/

19:30

Congress dinner